Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2624-2635

  Foster, Wendy K ^a   Miller, Darren S ^a   Marion, Patricia L ^b   Colonno, Richard J ^c   Kotlarski, Ieva ^a   Jilbert, Allison R ^a,b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; DNA VACCINE; ENTECAVIR; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; BILE DUCT; CONTROLLED STUDY; DISEASE MARKER; DNA REPLICATION; DNA VECTOR; DRUG EFFICACY; DUCK; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIREMIA; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; DNA, VIRAL; DUCKS; GUANINE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; LIVER; LIVER FUNCTION TESTS; VACCINATION; VACCINES, DNA; VIRAL HEPATITIS VACCINES; VIRUS REPLICATION;

EID: 0041767448     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2624-2635.2003     Document Type: Article

References (33)

1. Bock, C. T., P. Schranz, C. H. Schroder, and H. Zentgraf. 1994. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 8:215-229.
2. Chang, K. M., and F. V. Chisari. 1999. Immunopathogenesis of hepatitis B virus infection. Clin. Liver Dis. 3:221-239.
3. Chisari, F. V., and C. Ferrari. 1997. Viral hepatitis, p. 745-778. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
4. Colonno, R. J., E. V. Genovesi, I. Medina, L. Lamb, S. Durham, M. L. Huang, L. Corey, M. Littlejohn, S. Locarnini, B. C. Tennant, B. Rose, and J. M. Clark. 2001. Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. J. Infect. Dis. 184:1236-1245.
5. Fairbrother, A., M. A. Craig, K. Walker, and D. O'Loughlin. 1990. Changes in mallard (Anasplatyrhynchos) serum chemistry due to age, sex, and reproductive condition. J. Wildl. Dis. 26:67-77.
6. Fourel, I., J. M. Cullen, J. Saputelli, C. E. Aldrich, P. Schaffer, D. R. Averett, J. Pugh, and W. S. Mason. 1994. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J. Virol. 68:8321-8330.
7. Genovesi, E. V., L. Lamb, I. Medina, D. Taylor, M. Seifer, S. Innaimo, R. J. Colonno, D. N. Standring, and J. M. Clark. 1998. Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection. Antimicrob. Agents Chemother. 42:3209-3217.
8. Guo, J. T., C. E. Aldrich, W. S. Mason, and J. C. Pugh. 1996. Characterization of serum amyloid A protein mRNA expression and secondary amyloidosis in the domestic duck. Proc. Natl. Acad. Sci. USA 93:14548-14553.
9. Huang, A., C. A. Scougall, J. W. Lowenthal, A. R. Jilbert, and I. Kotlarski. 2001. Structural and functional homology between duck and chicken interferon-gamma. Dev. Comp. Immunol. 25:55-68.
10. Innaimo, S. F., M. Seifer, G. S. Bisacchi, D. N. Standring, R. Zahler, and R. J. Colonno. 1997. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 41:1444-1448.
11. Jilbert, A. R., J. A. Botten, D. S. Miller, E. M. Bertram, P. Hall, I. Kotlarski, and C. J. Burrell. 1998. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology 243:273-282.
12. Jilbert, A. R., J. S. Freiman, E. J. Gowans, M. Holmes, Y. E. Cossart, and C. J. Burrell. 1987. Duck hepatitis B virus DNA in liver, spleen and pancreas: analysis by in situ and Southern blot hybridization. Virology 158:330-338.
13. Jilbert, A. R., D. S. Miller, C. A. Scougall, H. Turnbull, and C. J. Burrell. 1996. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 226:338-345.
14. Jilbert, A. R., T. T. Wu, J. M. England, P. M. Hall, N. Z. Carp, A. P. O'Connell, and W. S. Mason. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 66:1377-1388.
15. Kent, S. J., A. Zhao, S. J. Best, J. D. Chandler, D. B. Boyle, and I. A. Ramshaw. 1998, Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180-10188.
16. Klingmuller, U., and H. Schaller. 1993. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. J. Virol. 67:7414-7422.
17. Lai, C., M. Rosmawati, J. Lao, H. Vlierberghe, F. Anderson, N. Thomas, and D. De Hertogh. 2001. A phase II study of entecavir vs. lamivudine in adults with chronic hepatitis B. J. Hepatol. 34:24.
18. Lee, J.-Y., J. G. Culvenor, P. Angus, R. Smallwood, A. Nicoll, and S. A. Locarnini. 2001. Duck hepatitis B virus replication in primary bile duct epithelial cells. J. Virol. 75:7651-7661.
19. Lenhoff, R. J., and J. Summers. 1994. Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes. J. Virol. 68:5706-5713.
20. Lin, E., C. Luscombe, D. Colledge, Y. Y. Wang, and S. A. Locarnini. 1998. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo. Antimicrob. Agents Chemother. 42:2132-2137.
21. Marion, P. L., F. H. Salazar, M. A. Winters, and R. J. Colonno. 2002. Potent efficacy observed with entecavir (BMS-200475) in a duck model of hepatitis B virus replication. Antimicrob. Agents Chemother. 46:82-88.
22. Mason, W. S., J. Cullen, G. Moraleda, J. Saputelli, C. E. Aldrich, D. S. Miller, B. C. Tennant, L. Frick, D. Averett, L. D. Condreay, and A. R. Jilbert. 1998. Lamivudine therapy of WHV infected woodchucks. Virology 245:18-32.
23. Mason, W. S., J. Cullen, J. Saputelli, T. T. Wu, C. Liu, W. T. London, E. Lustbader, P. Schaffer, A. P. O'Connell, I. Fourel, C. E. Aldrich, and A. R. Jilbert. 1994. Characterization of the antiviral effects of 2′ carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology 19:398-411.
24. Newbold, J. E., H. Xin, M. Tencza, G. Sherman, J. Dean, D. S. Bowden, and S. A. Locarnini. 1995. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 69:3350-3357.
25. Nicoll, A. J., D. L. Colledge, J. J. Toole, P. W. Angus, R. A. Smallwood, and S. A. Locarnini. 1998. Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl) adenine, an acyclic phosphonate nucleoside analogue. Antimicrob. Agents Chemother. 42:3130-3135.
26. Nicoll, A., S. A. Locarnini, S. T. Chou, R. Smallwood, and P. Angus. 2000. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo. J. Gastroenterol. Hepatol. 15:304-310.
27. Price, P. M., R. Banerjee, and G. Acs. 1992. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2′-deoxyguanosine. Hepatology 16:8-12.
28. Pugh, J. C., Q. Di, W. S. Mason, and H. Simmons. 1995. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J. Virol. 69:4814-4822.
29. Rollier, C., C. Sunyach, L. Barraud, N. Madani, C. Jamard, C. Trepo, and L. Cova. 1999. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 116:658-665.
30. Triyatni, M., P. L. Ey, H. Tran, M. F. LeMire, M. Qiao, C. J. Burrell, and A. R. Jilbert. 2001. Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses. J. Gen. Virol. 82:373-378.
31. Triyatni, M., A. R. Jilbert, M. Qiao, D. S. Miller, and C. J. Burrell. 1998. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72:84-94.
32. Yamanaka, G., T. Wilson, S. Innaimo, G. S. Bisacchi, P. Egli, J. K. Rinehart, R. Zahler, and R. J. Colonno. 1999. Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus. Antimicrob. Agents Chemother. 43:190-193.
33. Zhou, T., J. Saputelli, C. E. Aldrich, M. Deslauriers, L. D. Condreay, and W. S. Mason. 1999. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob. Agents Chemother. 43:1947-1954.